oral semaglutide cardiovascular benefit in Cardiometabolic Diseases: SELECTing the Target Population Oral Semaglutide in Older Adults

Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease

That's been shown for each (drug) compared to placebo, as well as in direct comparisons of one against the other for diabetes control and for weight loss

However, tirzepatides additional action on GIP hormones enhances its ability to regulate appetite and improve satiety, potentially leading to greater weight loss compared to semaglutide

When starting on a GLP-1, your appetite is going to decrease because it slows gastric emptying, and also works on the brain to control hunger

doi:10.1080/02640414.2013.771958